Accountable AI for autonomous work that answers for itself
Give an AI agent a wallet with spending limits and approval controls
Stage
Startup
MVP
Founded
2026
Not given
Based in
DE
IN
Pricing model
Paid
Free
Pricing
Founder $1,000/month, Team (up to 10 people) $3,000/month, Investor firm $3,000/month, Company from $10,000/month. Early members receive launch prices set on individual calls. Flat plans with unlimited jobs, no per-seat fees, and month-to-month billing.
Not given
Key features
Autonomous job planning and execution with parallel specialists
Independent verification check before results reach user
Integrates with existing apps and accounts without API requirements
Private per-customer workspace with encryption in transit and at rest
Corrections become rules for future runs
Full audit trail with source links for all findings
Month-to-month billing with no lock-in contract
Unlimited jobs on flat monthly pricing
Results within the hour after setup
Draft approval workflow for outbound communications
Trusted address list with immediate payment execution
Telegram-based approval for untrusted recipients
Hourly and daily spending limits
Automatic freeze on suspicious activity
SDKs for TypeScript, Python, and HTTP
Support for multiple blockchains
Emergency freeze and backup address recovery
x402 Payment Required protocol support
What makes it different
Answers for the work rather than just running tasks autonomously
No setup required; company handles configuration and ongoing management
Separate verification step ensures quality before delivery
Works across 35 AI providers through user's own API keys
Customer playbooks never shared with competitors
Non-custodial design: you hold your keys and vault; WalletBrake can only approve, refuse or freeze payments
On-chain enforcement: vault contract enforces all limits directly on blockchain
Protection against social engineering with 24-hour delay for adding trusted addresses
AI intent checking prevents off-topic or misaligned payments within approved tasks
Protection against address poisoning and new contract risks